ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

VRDN Viridian Therapeutics Inc

16.30
1.72 (11.80%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Viridian Therapeutics Inc VRDN NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
1.72 11.80% 16.30 09:00:00
始値 安値 高値 終値 前日終値
15.08 15.01 15.50 15.40 14.58
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0321:00BWViridian Therapeutics Announces Inducement Grants Under..
2024/4/2921:00BWViridian Therapeutics to Webcast First Quarter 2024..
2024/4/0505:01BWViridian Therapeutics Announces Inducement Grants Under..
2024/3/0706:01BWViridian Therapeutics Announces Inducement Grants Under..
2024/3/0522:00BWViridian Therapeutics to Participate in the Leerink Partners..
2024/2/2906:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/2806:07EDGAR2Form 8-K - Current report
2024/2/2806:01BWViridian Therapeutics Highlights Recent Progress and Reports..
2024/2/1622:00BWViridian Therapeutics Appoints Jennifer Tousignant as Chief..
2024/2/1510:28EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1506:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1506:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1506:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/2/1506:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1423:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0806:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0706:01BWViridian Therapeutics Announces Inducement Grant Under..
2024/1/2508:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2507:12EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/1/2007:22EDGAR2Form 8-K - Current report
2024/1/2006:32EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/1812:00BWViridian Therapeutics Announces Pricing of Public Offering..
2024/1/1806:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/1806:01BWViridian Therapeutics Announces Proposed Underwritten Public..
2024/1/1306:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0822:08EDGAR2Form 8-K - Current report
2024/1/0822:00BWViridian Therapeutics to Present Key 2024 Corporate..
2024/1/0422:00BWViridian Therapeutics to Webcast Presentation at the 42nd..
2023/12/1901:45EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1822:15EDGAR2Form 8-K - Current report
2023/12/1821:00BWViridian Therapeutics Announces Positive Clinical Data in..
2023/12/1306:19EDGAR2Form 144 - Report of proposed sale of securities
2023/12/0906:17EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/12/0806:22EDGAR2Form 144 - Report of proposed sale of securities
2023/12/0206:04EDGAR2Form 144 - Report of proposed sale of securities
2023/12/0106:05EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2023/11/2122:00BWViridian Therapeutics to Participate in 6th Annual Evercore..
2023/11/1407:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1406:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1406:01BWViridian Therapeutics Reports Third Quarter 2023 Financial..
2023/11/0822:00BWViridian Therapeutics to Participate in the Jefferies London..
2023/11/0405:30EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/11/0321:00BWViridian Therapeutics Announces Encore Presentations at the..
2023/11/0210:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0205:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/11/0205:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0205:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0205:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/10/3021:35EDGAR2Form 8-K - Current report
2023/10/3021:30BWViridian Therapeutics Appoints New Chief Executive Officer,..

最近閲覧した銘柄

Delayed Upgrade Clock